Cargando…
Obesity in achondroplasia patients: from evidence to medical monitoring
Achondroplasia is a rare genetic disease representing the most common form of short-limb dwarfism. It is characterized by bone growth abnormalities that are well characterized and by a strong predisposition to abdominal obesity for which causes are unknown. Despite having aroused interest at the end...
Autores principales: | Saint-Laurent, Celine, Garde-Etayo, Laura, Gouze, Elvire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854721/ https://www.ncbi.nlm.nih.gov/pubmed/31727132 http://dx.doi.org/10.1186/s13023-019-1247-6 |
Ejemplares similares
-
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia
por: Saint-Laurent, Celine, et al.
Publicado: (2018) -
Current Care and Investigational Therapies in Achondroplasia
por: Unger, Sheila, et al.
Publicado: (2017) -
In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia
por: Gonçalves, Diogo, et al.
Publicado: (2020) -
Longitudinal Imaging of the Skull Base Synchondroses Demonstrate Prevention of a Premature Ossification After Recifercept Treatment in Mouse Model of Achondroplasia
por: Rignol, Guylene, et al.
Publicado: (2021) -
Medical complications in children with achondroplasia
por: Armstrong, Jennifer A., et al.
Publicado: (2022)